Psychedelic-Specific Foundations

The Alexander Mosley Charitable Trust is a UK philanthropic foundation established in 2011 by Max Mosley in memory of his son, providing proactive grant-making to mental health and psychedelic research causes. The Trust is a principal funder of Imperial College London's Centre for Psychedelic Research, donating over £600,000 to support landmark psilocybin studies published in the New England Journal of Medicine and Nature Medicine.

The Anne and Don Fizer Foundation is a Houston, Texas-based private charitable foundation established in memory of estate planning attorney Don E. Fizer (1942–2011) and his wife Anne, supporting philanthropy in healthcare and medical research. The foundation has contributed to psychedelic research initiatives, participating in the growing wave of private philanthropic funding for clinical studies of psychedelic-assisted therapy in the United States.

Longstanding non-profit foundation supporting and convening psychedelic and drug-policy research programs.

Fundación Beckley Med is a Barcelona-based psychedelic research and education organisation, partnered with the UK's Beckley Foundation, that funds and disseminates psychedelic-assisted therapy studies and provides professional training through institutional affiliations with MAPS, Grof Legacy, and CIIS. It collaborated with CITA Clinic to deliver experimental ketamine treatment to patients with treatment-resistant depression in Spain.

The Brain & Behavior Research Foundation (formerly NARSAD) is the world's largest private funder of psychiatric research, having awarded over $475 million to more than 5,000 scientists—including grants specifically supporting psilocybin-assisted therapy trials, ketamine research, and other innovative treatments for depression, PTSD, and schizophrenia. In 2023 alone, the foundation funded seven grants advancing psilocybin-based research and has supported over 90 ketamine-related projects, making it a cornerstone funder of emerging psychedelic science.

Canada-based foundation backing translational and clinical research programs in mental health, including psychedelic-relevant workstreams.

The Carey and Claudia Turnbull Family Foundation is a private philanthropic foundation that has been one of the earliest and most influential funders of psychedelic medicine research, supporting psilocybin studies at NYU, Yale, and Johns Hopkins—including helping establish Yale’s psychedelic psychiatry training curriculum and endowing research at the NYU Center for Psychedelic Medicine, where Carey Turnbull chairs the advisory board. Carey Turnbull also serves as President of the Heffter Research Institute and co-founded B.More and Ceruvia Lifesciences, further extending the family’s commitment to advancing psychedelic therapies for depression, addiction, and OCD.

The Council on Spiritual Practices (CSP) is a US non-profit organisation founded in 1993 by Robert Jesse to support research and education on the safe and effective use of entheogens and primary religious experience. CSP was instrumental in initiating the landmark Johns Hopkins psilocybin research programme with Roland Griffiths, co-funding pivotal early studies on psilocybin's mystical-experience effects that re-established psychedelic science and shaped clinical frameworks globally.

The Council on Spiritual Practices Fund at the San Francisco Foundation is a named charitable fund administered through the San Francisco Foundation, a regional community foundation serving the Bay Area. It channels philanthropic resources in support of research and education on entheogenic substances and primary religious experience, extending the grant-making mission of the Council on Spiritual Practices through a community foundation structure.

Empower Psychedelics is a Canada-based non-profit conducting Health Canada-approved psychedelic-assisted group therapy research for first responders and military veterans in partnership with MAPS Canada. Founded in 2020 by former first responders, the organization received a $205K Mitacs grant with the University of Quebec in Montreal for a two-year clinical research program.

Empower Research Inc. is the corporate research entity behind Empower Psychedelics, running Health Canada-approved trials on psychedelic-assisted group therapy for first responders in partnership with MAPS Canada. The organization has also studied medically perceived benefits of psychedelics and cannabinoids among first responders and military personnel.

The Etheridge Foundation is a 501(c)(3) non-profit founded by Grammy and Academy Award-winning musician Melissa Etheridge following the 2020 opioid overdose death of her son Beckett, funding scientific research into plant-medicine treatments for opioid use disorder and related mental health conditions. The Foundation has co-funded Usona Institute's 5-MeO-DMT research program and raised over $1 million at its inaugural Rock Jam gala for psychedelic medicine development.

The Michael J. Fox Foundation for Parkinson's Research (MJFF) is a New York-based non-profit founded in 2000 by actor Michael J. Fox that has raised over $2 billion for Parkinson's disease research and treatments. MJFF has funded pioneering psychedelic research including the first psilocybin trial in a neurodegenerative disease (UCSF/Yale, for Parkinson's-related depression) and a ketamine infusion trial at Yale for treatment-resistant depression in Parkinson's patients.

The George Sarlo Foundation is the philanthropic vehicle of Holocaust survivor and Silicon Valley venture capitalist George Sarlo, who credits guided psychedelic experiences with resolving his childhood trauma and became one of the earliest major private donors to psychedelic science. The Foundation has contributed nearly $2 million to psychedelic research, including a $1 million pledge to MAPS for MDMA-assisted therapy development and grants to CIIS for psychedelic therapist diversity training.

The Antonio J. Gracias Family Foundation is a Chicago-based private philanthropic foundation established in 2021 that awarded a $16 million gift to Harvard University to fund interdisciplinary psychedelic research, including the Project on Psychedelics Law and Regulation (POPLAR) at Harvard Law School and the Transcendence and Transformation Initiative at the Center for the Study of World Religions. With $94.6 million in assets, the foundation identifies psychedelics as a priority research area alongside quantum science and cardiovascular medicine.

Healing Hearts, Changing Minds, Inc. (HHCM) is a Massachusetts-based nonprofit grant foundation committed to trust-based philanthropy in psychedelic-assisted therapy, founded by Robert Ansin following a transformative personal psilocybin experience. The foundation has awarded over $566,000 in grants under its 'Walking Each Other Home' fund to support psilocybin and ketamine-assisted therapy in end-of-life care, including funding for war-affected Ukrainian veterans.

Non-profit organization funding and coordinating research on classic psychedelics and related therapies.

Platform organization developing and supporting psychedelic and mental-health initiatives with philanthropic backing.

ICEERS (International Center for Ethnobotanical Education, Research and Service) is a nonprofit supporting ethnobotanical research, policy engagement, and community-informed programming around ayahuasca, iboga, and related plant medicines.

Private foundation with explicit support for psychedelic research, science communication, and ecosystem development.

Philanthropic initiative focused on funding and scaling mental-health innovation, including psychedelic-related ecosystem efforts.

Dutch nonprofit organizer in the psychedelic field, including stewardship of the ICPR conference series and related professional convenings.

The Oppenheimer Family Psychosocial Oncology and Palliative Care Research Grants is a philanthropic grant fund supporting research at Dana-Farber Cancer Institute's Department of Psychosocial Oncology and Palliative Care, including Dr. Yvan Beaussant's psilocybin-assisted therapy studies for demoralization and existential distress in hospice patients. The program co-funds trials alongside the Heffter Research Institute, Usona Institute, and Nikean Foundation.

Foundation funding psychedelic and mental-health innovation programs, linked to HumanKindLabs initiatives.

Private Philanthropic Funds is a ClinicalTrials.gov funder category representing anonymous private philanthropic donors, appearing as a collaborator on Johns Hopkins University research including the Phase 1 safety study for at-home administration of microdose psilocybin (NCT06450210). The Psychedelic Science Funders Collaborative (psfc.co) is the leading coordinating body for such private philanthropists dedicated to advancing psychedelic therapy research.

Foundation funding psychedelic science, policy, and education initiatives across the emerging ecosystem.

Private foundation with publicly documented support for psychedelic and mental-health research initiatives.

The philanthropic vehicle of the Council on Spiritual Practices (CSP), administered as Fund #4745 within the San Francisco Foundation. CSP is a nonprofit organization that played a foundational role in supporting psilocybin research at Johns Hopkins University, including landmark studies on mystical experience, spiritual practice, and the therapeutic potential of psychedelics.

Czech philanthropic foundation supporting research and public education initiatives related to psychedelics.

A nonprofit organization based in San Anselmo, California, dedicated to advancing the therapeutic use of ketamine and psychedelic medicines. Founded by Dr. Phil Wolfson, the Ketamine Research Foundation conducts FDA-approved clinical research on ketamine-assisted psychotherapy, operates the premier Ketamine Training Center, and maintains a comprehensive scholarly library on ketamine therapeutics.

Named endowed-funding initiative supporting sustained psychedelic science leadership at Johns Hopkins.

The Wallace Foundation is a US national philanthropy that funds research and practice in education, arts, and youth development. The foundation supports programs that expand learning opportunities for disadvantaged young people and strengthen cultural organizations. Its presence in clinical research records may reflect its growing interest in youth mental health and social-emotional learning initiatives.

Foundation supporting mental-health and psychedelic-adjacent initiatives with explicit wellbeing and societal impact framing.

A nonprofit philanthropic organization dedicated to supporting Vail Health and its affiliated behavioral health programs in Eagle County, Colorado. The Vail Health Foundation generates philanthropy for Shaw Cancer Center, Eagle Valley Behavioral Health, and allied community nonprofits, with a $100 million campaign focused on transforming behavioral health care across mountain communities.